Alexion Pharmaceuticals, Inc. Return on Tangible Equity 2010-2021 | ALXN

Current and historical return on tangible equity values for Alexion Pharmaceuticals, Inc. (ALXN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2021-03-31 $0.68B $4.28B 19.34%
2020-12-31 $0.60B $3.55B 19.62%
2020-09-30 $0.96B $2.92B 32.85%
2020-06-30 $0.85B $3.36B 31.80%
2020-03-31 $2.38B $2.49B 106.30%
2019-12-31 $2.41B $2.89B 127.30%
2019-09-30 $1.47B $1.92B 114.16%
2019-06-30 $1.33B $1.64B 146.07%
2019-03-31 $0.42B $1.11B 85.54%
2018-12-31 $0.08B $0.49B 29.91%
2018-09-30 $0.15B $0.42B 133.92%
2018-06-30 $-0.10B $-0.06B 459.77%
2018-03-31 $0.52B $0.20B -703.03%
2017-12-31 $0.44B $-0.10B -196.45%
2017-09-30 $0.51B $-0.13B -139.59%
2017-06-30 $0.52B $-0.27B -89.77%
2017-03-31 $0.48B $-0.40B -55.50%
2016-12-31 $0.40B $-0.65B -34.33%
2016-09-30 $0.37B $-1.00B -27.13%
2016-06-30 $0.10B $-1.39B -6.28%
2016-03-31 $0.15B $-1.62B -9.76%
2015-12-31 $0.14B $-1.50B -34.89%
2015-09-30 $0.23B $-1.55B 39.88%
2015-06-30 $0.59B $-1.28B 38.63%
2015-03-31 $0.59B $2.68B 24.92%
2014-12-31 $0.66B $2.46B 30.49%
2014-09-30 $0.48B $2.27B 25.27%
2014-06-30 $0.40B $2.03B 23.37%
2014-03-31 $0.33B $1.84B 21.53%
2013-12-31 $0.25B $1.52B 18.47%
2013-09-30 $0.35B $1.46B 28.07%
2013-06-30 $0.35B $1.31B 30.88%
2013-03-31 $0.29B $1.19B 28.74%
2012-12-31 $0.25B $1.07B 32.45%
2012-09-30 $0.22B $0.97B 29.24%
2012-06-30 $0.20B $0.82B 26.57%
2012-03-31 $0.19B $0.27B 26.79%
2011-12-31 $0.18B $0.96B 21.00%
2011-09-30 $0.15B $0.88B 19.22%
2011-06-30 $0.12B $0.78B 15.02%
2011-03-31 $0.10B $0.73B 13.48%
2010-12-31 $0.10B $0.82B 12.83%
2010-09-30 $0.31B $0.77B 43.26%
2010-06-30 $0.31B $0.75B 49.94%
2010-03-31 $0.30B $0.70B 58.96%
2009-12-31 $0.30B $0.64B 75.03%